Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome
暂无分享,去创建一个
Ilka Hoof | Can Kesmir | I. Hoof | A. I. Costa | S. Spijkers | D. van Baarle | M. Poelen | C. V. van Els | Ingrid M. M. Schellens | Hugo D. Meiring | Sanne N. M. Spijkers | Martien C. M. Poelen | Jacqueline A. M. van Gaans-van den Brink | Kees van der Poel | Ana I. Costa | Cecile A. C. M. van Els | Debbie van Baarle | C. Keşmir | H. Meiring | J. A. M. van Gaans-van den Brink | Kees van der Poel
[1] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[2] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[3] H. Eisen,et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.
[4] V. Levitsky,et al. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4 , 1996, The Journal of experimental medicine.
[5] S. H. van der Burg,et al. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. , 1996, Journal of immunology.
[6] D. Busch,et al. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. , 1998, Journal of immunology.
[7] C. Melief,et al. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. , 1998, Journal of immunology.
[8] H. Rammensee,et al. Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides , 1998, The Journal of experimental medicine.
[9] C. Herberts,et al. A microcapillary column switching HPLC-electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules. , 1998, Analytical chemistry.
[10] C. Herberts,et al. A single naturally processed measles virus peptide fully dominates the HLA‐A*0201‐associated peptide display and is mutated at its anchor position in persistent viral strains , 2000, European journal of immunology.
[11] H. Meiring,et al. Nanoscale LC–MS(n): technical design and applications to peptide and protein analysis , 2002 .
[12] N. Shastri,et al. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.
[13] M. Villacres,et al. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. , 2003, Human immunology.
[14] E. Hewitt. The MHC class I antigen presentation pathway: strategies for viral immune evasion , 2003, Immunology.
[15] Ed van der Heeft,et al. Dynamics of measles virus protein expression are reflected in the MHC class I epitope display. , 2003, Molecular immunology.
[16] H. Whittle,et al. Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02-Restricted Measles Virus Epitope in Patients with Measles , 2003, Journal of Virology.
[17] R. Vierkant,et al. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. , 2003, Vaccine.
[18] Muthuraman Sathiamurthy,et al. Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1 , 2004, The Journal of Immunology.
[19] Bette Korber,et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.
[20] Etienne Caron,et al. The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. , 2005, International immunology.
[21] J. Yewdell,et al. The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.
[22] O. Lund,et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.
[23] Matthew S. Cook,et al. Immunodominant Tuberculosis CD8 Antigens Preferentially Restricted by HLA-B , 2007, PLoS pathogens.
[24] Morten Nielsen,et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..
[25] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[26] Nina Hillen,et al. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype , 2008, European journal of immunology.
[27] David K. Crockett,et al. Large Scale Mass Spectrometric Profiling of Peptides Eluted from HLA Molecules Reveals N-Terminal-Extended Peptide Motifs1 , 2008, The Journal of Immunology.
[28] Hidde L. Ploegh,et al. The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.
[29] Morten Nielsen,et al. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers , 2008, Bioinform..
[30] A Novel Trafficking Signal within the HLA-C Cytoplasmic Tail Allows Regulated Expression upon Differentiation of Macrophages1 , 2008, The Journal of Immunology.
[31] D. van Baarle,et al. A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses1 , 2009, The Journal of Immunology.
[32] David Burgner,et al. HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.
[33] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[34] James Robinson,et al. The IMGT/HLA database , 2008, Nucleic Acids Res..
[35] M. Knittler,et al. Post-Endoplasmic Reticulum Rescue of Unstable MHC Class I Requires Proprotein Convertase PC7 , 2010, The Journal of Immunology.
[36] Wilfried Bardet,et al. HLA class I molecules reflect an altered host proteome after influenza virus infection. , 2010, Human immunology.
[37] E. Wiertz,et al. Herpesviruses and immunity: the art of evasion. , 2010, Veterinary microbiology.
[38] Ilan Beer,et al. The HLA-B*2705 peptidome. , 2010, Arthritis and rheumatism.
[39] Christian von Mering,et al. Shotgun proteomics data from multiple organisms reveals remarkable quantitative conservation of the eukaryotic core proteome , 2010, Proteomics.
[40] J. Neefjes,et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.
[41] R. Vierkant,et al. Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose. , 2011, Vaccine.
[42] Arie Admon,et al. The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing , 2011, Molecular & Cellular Proteomics.
[43] Bjoern Peters,et al. Insights into HLA-Restricted T Cell Responses in a Novel Mouse Model of Dengue Virus Infection Point toward New Implications for Vaccine Design , 2011, The Journal of Immunology.
[44] S. Stevanović,et al. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands , 2011, Cellular and Molecular Life Sciences.
[45] Ilka Hoof,et al. Proteome Sampling by the HLA Class I Antigen Processing Pathway , 2012, PLoS Comput. Biol..
[46] Nicholas A Williamson,et al. Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. , 2012, Molecular immunology.
[47] Morten Nielsen,et al. Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.
[48] F. Canals,et al. Peptides presented by HLA class I molecules in the human thymus. , 2013, Journal of proteomics.
[49] The UniProt Consortium,et al. Update on activities at the Universal Protein Resource (UniProt) in 2013 , 2012, Nucleic Acids Res..
[50] Nina Hillen,et al. Exploring the MHC-peptide matrix of central tolerance in the human thymus , 2013, Nature Communications.
[51] Peter Cresswell,et al. Pathways of antigen processing. , 2013, Annual review of immunology.
[52] J. Leunissen,et al. The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes* , 2013, Molecular & Cellular Proteomics.
[53] María Martín,et al. Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..
[54] Albert J R Heck,et al. Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) , 2014, Proceedings of the National Academy of Sciences.